- Home
- TORO vs BRNS Comparison
TORO vs BRNS Comparison
Compare TORO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- BRNS
- Stock Information
- Founded
- TORO 2022
- BRNS 2016
- Country
- TORO Cyprus
- BRNS United Kingdom
- Employees
- TORO N/A
- BRNS N/A
- Industry
- TORO Marine Transportation
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- TORO Consumer Discretionary
- BRNS Health Care
- Exchange
- TORO Nasdaq
- BRNS Nasdaq
- Market Cap
- TORO 36.7M
- BRNS 36.0M
- IPO Year
- TORO N/A
- BRNS 2021
- Fundamental
- Price
- TORO $2.93
- BRNS $1.00
- Analyst Decision
- TORO
- BRNS Strong Buy
- Analyst Count
- TORO 0
- BRNS 1
- Target Price
- TORO N/A
- BRNS $3.00
- AVG Volume (30 Days)
- TORO 752.9K
- BRNS 17.8K
- Earning Date
- TORO 08-11-2025
- BRNS 08-07-2025
- Dividend Yield
- TORO N/A
- BRNS N/A
- EPS Growth
- TORO N/A
- BRNS N/A
- EPS
- TORO 1.09
- BRNS N/A
- Revenue
- TORO $22,394,283.00
- BRNS $14,969,000.00
- Revenue This Year
- TORO N/A
- BRNS N/A
- Revenue Next Year
- TORO N/A
- BRNS N/A
- P/E Ratio
- TORO $2.78
- BRNS N/A
- Revenue Growth
- TORO 0.40
- BRNS 4381.74
- 52 Week Low
- TORO $1.70
- BRNS $0.64
- 52 Week High
- TORO $4.05
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- TORO 75.13
- BRNS 55.94
- Support Level
- TORO $2.12
- BRNS $0.90
- Resistance Level
- TORO $2.29
- BRNS $1.10
- Average True Range (ATR)
- TORO 0.20
- BRNS 0.06
- MACD
- TORO 0.05
- BRNS 0.01
- Stochastic Oscillator
- TORO 71.13
- BRNS 60.00
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.